Autoimmune Hepatitis clinical trials at UCSF
1 research study open to eligible people
Autoimmune hepatitis is when the immune system mistakenly attacks the liver. UCSF is conducting studies to identify risks in patients with liver cirrhosis. These trials focus on understanding and predicting serious health issues in adults with autoimmune hepatitis.
Liver Cirrhosis Network Cohort Study
open to eligible people ages 18 years and up
Liver Cirrhosis Network (LCN) Cohort Study is an observational study designed to identify risk factors and develop prediction models for risk of decompensation in adults with liver cirrhosis. LCN Cohort Study involves multiple institutions and an anticipated 1200 participants. Enrolled participants will have study visits every 6 months (180 days), with opportunities to complete specific visit components via telehealth or remotely. Visits will include collection of questionnaire data and the in-person visits will include questionnaires, physical exams, imaging, and sample collection.
San Francisco, California and other locations